89 related articles for article (PubMed ID: 25680952)
1. Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.
Lang BH; Wong CK; Chan CT
Eur J Surg Oncol; 2015 Jun; 41(6):758-65. PubMed ID: 25680952
[TBL] [Abstract][Full Text] [Related]
2. Differentiated thyroid cancer: millions spent with no tangible gain?
Furuya-Kanamori L; Sedrakyan A; Onitilo AA; Bagheri N; Glasziou P; Doi SAR
Endocr Relat Cancer; 2018 Jan; 25(1):51-57. PubMed ID: 29042396
[TBL] [Abstract][Full Text] [Related]
3. The clinical and economic burden of a sustained increase in thyroid cancer incidence.
Aschebrook-Kilfoy B; Schechter RB; Shih YC; Kaplan EL; Chiu BC; Angelos P; Grogan RH
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1252-9. PubMed ID: 23677575
[TBL] [Abstract][Full Text] [Related]
4. High default rate in thyroid cancer management in Ibadan, Nigeria: a need for health insurance.
Adedapo KS; Fadiji IO; Orunmuyi AT; Ejeh JE; Osifo BO
Afr J Med Med Sci; 2012 Dec; 41 Suppl():105-9. PubMed ID: 23678644
[TBL] [Abstract][Full Text] [Related]
5. Annual financial impact of well-differentiated thyroid cancer care in the United States.
Lubitz CC; Kong CY; McMahon PM; Daniels GH; Chen Y; Economopoulos KP; Gazelle GS; Weinstein MC
Cancer; 2014 May; 120(9):1345-52. PubMed ID: 24481684
[TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
7. Cost-effective management of low-risk papillary thyroid carcinoma.
Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
[TBL] [Abstract][Full Text] [Related]
8. Attributable costs of differentiated thyroid cancer in the elderly Medicare population.
Boltz MM; Hollenbeak CS; Schaefer E; Goldenberg D; Saunders BD
Surgery; 2013 Dec; 154(6):1363-9; discussion 1369-70. PubMed ID: 23973115
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of major adult visual disorders in the United States.
Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
[TBL] [Abstract][Full Text] [Related]
10. Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.
Zanocco K; Kaltman DJ; Wu JX; Fingeret A; Heller KS; Lee JA; Yeh MW; Sosa JA; Sturgeon C
Ann Surg Oncol; 2018 Apr; 25(4):949-956. PubMed ID: 29417402
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
13. Annual financial impact of thyroidectomies for nodular thyroid disease in China.
Liu XY; Zhu LJ; Cui D; Wang ZX; Chen HH; Duan Y; Shen MP; Zhang ZH; Wang XD; Chen JW; Alexander EK; Yang T
Asian Pac J Cancer Prev; 2014; 15(14):5921-6. PubMed ID: 25081723
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract][Full Text] [Related]
15. Economic implications of hip fracture: health service use, institutional care and cost in Canada.
Wiktorowicz ME; Goeree R; Papaioannou A; Adachi JD; Papadimitropoulos E
Osteoporos Int; 2001; 12(4):271-8. PubMed ID: 11420776
[TBL] [Abstract][Full Text] [Related]
16. A cost-minimization analysis comparing total thyroidectomy alone and total thyroidectomy with prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Lang BH; Wong CK
Ann Surg Oncol; 2014 Feb; 21(2):416-25. PubMed ID: 23982258
[TBL] [Abstract][Full Text] [Related]
17. Disease control of differentiated thyroid carcinomas by hemithyroidectomy.
Chow TL; Choi CY; Lam SH
Singapore Med J; 2010 Apr; 51(4):311-4. PubMed ID: 20505909
[TBL] [Abstract][Full Text] [Related]
18. Cost for treatment and follow-up of thyroid cancer increases according to the severity of disease.
Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Kwon SS; Shin H; Chang HS; Park CS
Head Neck; 2019 Jul; 41(7):2376-2379. PubMed ID: 30784141
[TBL] [Abstract][Full Text] [Related]
19. Cost disparity between health care systems--it's not the surgeons: A cost analysis of thyroid cancer care between the United States and France.
Finnerty BM; Brunaud L; Mirallie E; McIntyre C; Aronova A; Fahey TJ; Zarnegar R
Surgery; 2016 Jan; 159(1):132-40. PubMed ID: 26435427
[TBL] [Abstract][Full Text] [Related]
20. Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancer.
Adkisson CD; Howell GM; McCoy KL; Armstrong MJ; Kelley ML; Stang MT; Joyce JM; Hodak SP; Carty SE; Yip L
Surgery; 2014 Dec; 156(6):1453-59; discussion 1460. PubMed ID: 25456931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
